ArticleFrontiers in cardiovascular medicine2025
Closed atrium bipolar radiofrequency box lesion for concomitant surgical atrial fibrillation ablation.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In patients with atrial fibrillation (AF) undergoing coronary artery bypass grafting (CABG) or aortic valve replacement (AVR), many surgeons are reluctant to open the left atrium for surgical ablation. However, especially in those with persistent AF, a box lesion isolating the entire posterior left atrial wall may be beneficial. Here, we describe our initial experience with a novel closed atrium bipolar radio-frequency left atrial box ablation technique. Methods: Between January 2023 and June 2024, 22 patients underwent the closed atrium radio-frequency box lesion set. Left left atrial appendage (LAA) closure was performed using an LAA clip in all patients. We evaluated the technical feasibility, safety, and efficacy of this new concomitant surgical AF ablation approach. Results: The mean patient age was 67.9 ± 5.3 years, and 68.2% were male. 12 patients (54.5%) had persistent AF, while 10 (45.5%) had paroxysmal AF. Creation of a complete box lesion from the right side was feasible in 14 patients; in 8 patients, the lesion had to be completed from the left side. No major ablation-related complications occurred. Successful intraoperative LAA closure was confirmed by TEE in all patients. There were no periprocedural strokes, and in-hospital mortality was 0%. Freedom from AF was 86.4% at discharge and 77.2% at a mean follow-up of 12.6 ± 3.9 months. Conclusion: The closed atrium left atrial box lesion technique for surgical treatment of AF concomitant with CABG or AVR is safe and technically feasible. This approach enables complete isolation of the posterior left atrial wall without the need to open the left atrium.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.